HIV Prevention and PrEP: Laying the Foundation
Released On
November 30, 2023
Expires On
November 30, 2024
Media Type
Internet
Completion Time
90 minutes
Specialty
Infectious Disease, Obstetrics & Gynecology, Pharmacy, Primary Care
Topic(s)
AIDS/HIV, Sexually Transmitted Diseases
Acknowledgement
This activity is provided by Talem Health and RME Collaborative.
In collaboration with the Southeast AIDS Education & Training Center.
This activity is supported by an independent educational grant from Gilead Sciences, Inc.
Credit Available
- Physicians — maximum of 1.5 AMA PRA Category 1 Credits™
- Nurses — 1.5 Contact Hours (0.5 contact hour of pharmacotherapy credit)
- Pharmacists — 1.5 Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity is designed specifically for primary care clinicians, nurses, pharmacists, and other members of the healthcare team who serve patients in rural and underserved communities.
Program Overview
Despite its proven benefits over the last decade, pre-exposure prophylaxis (PrEP) remains widely underutilized in rural and underserved communities that face high rates of new HIV diagnoses. Various barriers to PrEP uptake persist in these areas including stigma, lack of knowledge, and inadequate skills to prescribe or recommend HIV prevention strategies. This activity, which is part of a two-part series titled PrEP Uptake and Delivery: Strategies for Reducing Barriers in Rural and Underserved Communities, will cover best practices for discussing sexual history and the need for PrEP with patients in an open, nonjudgmental manner. Evidence-based guidance for initiating and maintaining appropriate candidates on PrEP will also be discussed.
This activity is a recording from a two-part webinar series that took place in August 2023. Please note that any data, information, and guidance presented in the activity are subject to change.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Utilize best practices to facilitate open conversation about sexual history and health
- Describe the recommended regimens for PrEP, including dosing, safety, efficacy, and clinical eligibility
- Incorporate strategies to facilitate access to PrEP among rural and underserved populations
Faculty
Onyema E. Ogbuagu, MD, FACP, FIDSA
Associate Professor of Medicine
Director, Antivirals and Vaccines Research Program
Yale School of Medicine
Attending Physician, Infectious Diseases
Yale-New Haven Health, Yale Medicine
New Haven, CT
Cody A. Chastain, MD, FACP, FIDSA
Assistant Professor of Medicine
Assistant Dean, Undergraduate Medical Education Program Evaluation and Improvement
Vanderbilt University School of Medicine
Principal Investigator, Southeast AIDS Education and Training Center
Attending Physician, Infectious Diseases
Vanderbilt University Medical Center
Nashville, TN
Joint Accreditation Statement
In support of improving patient care, Talem Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Physician Continuing Medical Education
Talem Health designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours. Designated for 0.5 contact hour of pharmacotherapy credit for Advanced Practice Registered Nurses.
Continuing Pharmacy Education
Talem Health designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number – JA4008332-0000-23-005-H01-P)
Type of Activity: Application
For Pharmacists: Upon successfully completing the post-test with a score of 75% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service.
Disclosure of Conflicts of Interest
Talem Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All identified conflicts of interest are thoroughly vetted and mitigated according to Talem Health policy. Talem Health is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
All relevant financial relationships have been mitigated.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
Faculty
Onyema E. Ogbuagu, MD, FACP, FIDSA, has disclosed the following relevant financial relationships: consultant/advisory board member for Gilead Sciences, Inc., Janssen Pharmaceuticals, and ViiV Healthcare; speakers’ bureau/honoraria from Gilead Sciences, Inc.
Cody A. Chastain, MD, FACP, FIDSA, has no relevant financial relationships to disclose.
Planners, Managers, and Reviewer
The Talem Health planners, managers, and reviewer have nothing to disclose.
Instructions for Participation and Credit
This activity is offered at no cost to participants. To receive CME credit, participants must:
- Read the CME/CE information, including learning objectives and disclosure statements.
- Complete the pre-test.
- View the online activity.
- Complete the post-test and evaluation form.
A post-test score of 75% or higher is required to obtain credit. Your certificate will be made available for immediate download.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
©RME Collaborative, a division of Talem Health, LLC. All Rights Reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Talem Health, LLC is prohibited.
Media
Internet activity
Fee Information
There is no fee for this educational activity.
Contact Information
For questions about this activity, please contact RME Collaborative (a division of Talem Health) at 800-913-9370 or [email protected].